Introduction
The number of cancer survivors has increased rapidly due to increased incidence of overall cancer and the improved survival of cancer patients (Boyle and Levin, 2008; Jung et al., 2011) . The proportion of cancer survivors is up to 3.7% in the United States and 1% in Korea (National Cancer Information Center, 2011; National Cancer Institute, 2012) . Cancer survivors have more comorbidities than the general population (Shin et al., 2008) . Furthermore, cancer survivors had an increased risk of developing cardiovascular disease as results of late effects of several cancer therapies such as platinum compounds, angiogenesis inhibitors, and radiation treatment (Redig and Munshi, 2010) . Thus, evaluation and management of accompanied comorbidities as well as survival itself have become important issues in cancer survivors. Cardiovascular disease is the most important cause of non-cancer death in cancer-survivors that affect life expectancy and quality of life (Brown et al., 1993; Shin et al., 2010a) . It is now well recognized that metabolic syndrome is associated with increased risk of cardiovascular events and mortality (Gami et al., 2007) . Therefore, risk for cardiovascular disease could be assessed by measuring metabolic syndrome components (Cabre et al., 2008) .
Previous studies showed inconsistent results whether the risk of metabolic syndrome is more increased in cancer survivors than general populations. In long-term survivors of childhood cancer, the trends for increased risk of metabolic syndrome were observed in several studies (Talvensaari et al., 1996; Follin et al., 2006; Gurney et al., 2006; Oeffinger et al., 2006; Annaloro et al., 2008) . As for survivors of adult-onset solid tumors, most studies were limited to some specific cancer types such as testicular cancer and prostate cancer (Nuver et al., 2005; Braga-Basaria et al., 2006; Haugnes et al., 2007) . Several studies from adult-onset solid tumors have demonstrated that the results were inconsistent according to types of cancer and treatment modalities (Nuver et 1774 Haugnes et al., 2007; Liavaag et al., 2009; Ulaganathan et al., 2012) . A recent meta-analysis showed no significant association with metabolic syndrome for non-hematologic malignancies (Jung et al., 2012) .
Few studies about the association between metabolic syndrome and cancer survivors have been performed in Asia, where the leading causes of cancer differ from Western countries. In Korea, the top five prevalent cancer types are the stomach, colorectum, liver, prostate, and lung among male cancer survivors, whereas thyroid, breast, stomach, colorectum, and cervix uteri are the top five among female (Jung et al., 2011) . The risk of metabolic syndrome in Korean cancer survivors could be affected from the differences in race and in leading cancer types. Moreover, socio-demographic, behavioral, and cultural factors of Korean cancer survivors are different from western countries, and could affect the long-term consequences. The objectives are to evaluate the prevalence of metabolic syndrome and identify risk factors, including oncological and non-oncological factors, among Korean cancer survivors.
Materials and Methods

Overview of survey and study population
The fourth Korean National Health and Nutrition Examination Survey 2007-2009 (KNHANES IV) was a nationally representative survey conducted by the Division of Chronic Disease Surveillance under the Korea Centers for Disease Control and Prevention on an annual basis since 1998 to accurately determine national health and nutrition levels and for the purpose of gaining basic data (Korea Centers for Disease Control and Prevention, 2010) . The survey is composed of 3 parts: (1) health interview survey, (2) health examination survey, and (3) nutritional survey. A face to face interview at participants' home by trained interviewers was applied to gather health interview survey. The standardized health examination survey was conducted in specially equipped mobile examination centers.
A stratified multistage clustered probability sampling was used to choose a representative sample of the noninstitutional civilian population (see Figure 1) 23,631 (4246 in 2007, 9307 in 2008, and 10078 in 2009 ) individuals aged ≥10 years. After excluding 12,003 participants aged less than 40 years, 11,628 subjects were used for the current study. Subjects with any missing data for the metabolic syndrome component of the survey were excluded (n=622). The subjects included in our study were 11,006 persons who were aged ≥ 40 years and completed tests for metabolic syndrome component. Cancer survivors were classified if they reported having ever been told by a doctor that they had cancer or a malignancy of any kind. The cancer survivors were 335 persons as the final population. Institutional Review Board approval was waived due to using open data sets to public.
Associated factors and definition of metabolic syndrome
We collected information about various factors that could be associated with risk of metabolic syndrome. We assessed variables related to socio-demographic factors, behavioral factors, psychological factors, and oncological factors. The socio-demographic variables were sex, current age (<60 years and ≥60 years), education level (less than elementary school, middle/ high school, and more than college), monthly household income (<573 $, 573-1,332$ and ≥1,332$) and residential area (urban or rural). Household monthly income was divided into tertiles, and income per adult equivalent was calculated using the formula household income/square root of the number of persons in the household.
Behavioral risk factors included body mass index (BMI), current smoking status (no or yes), heavy alcohol consumption (no or yes), and the level of physical activity (inadequate or adequate). BMI was obtained from each subjects and categorized as follows: <23, 23−25, and ≥25 (WHO, 2000) . Heavy alcohol consumption was defined as consumption of 5 or more drinks on a single occasion, or drinking almost every day. Subjects were asked about their average frequency and amount of alcoholic beverage intake during the year before the interview. Heavy alcohol consumption was defined by self-reported Subjects who participated in KNHANES IV (n = 24,871) Subjects who participated in blood test (n = 23,631) Subjects aged more than 40 years (n = 11,628) Excluded individuals who did not participate in blood test (n = 1,240) Excluded subjects aged less than 40 years (n = 12,003) Subjects who completed tests for metabolic syndrome components (n = 11,006) Excluded subjects who had missing data for metabolic syndrome components (n = 622) (Amparo et al., 2011) . We defined adequate physical activity as doing 30 minutes of moderate-intensity physical activity on 5 or more days of the week or 20 minutes of vigorous-intensity physical activity on 3 or more days of the week as recommended by the American College of Sports Medicine and the American Heart Association (Haskell et al., 2007) .
Psychological factors were self-reported depression (no or yes) and suicidal ideation within 1 year (no or yes). Self-reported depression was determined if participants reported having ever been diagnosed as depression by a doctor. Oncological factors were cancer types (gastric, breast, cervix uteri, and other cancer type) and duration since diagnosis (<5, 5−10, ≥10 years). Cancer survivors were also asked about the site and the age of diagnosis. In our study, we classified cancer types as gastric, colon, breast, cervix uteri, and other cancer. The cancer type which included less than 20 subjects was classified as other cancer. Therefore, several common cancers such as liver, lung, prostate, thyroid, esophagus, pancreas, and ovary were classified as other cancer type due to small number in this survey.
Metabolic syndrome were defined as a combination of clinical disorders that includes the presence of three or more indicators: 1) abdominal obesity (waist circumference >90 cm in males or 80 cm in females), standard values modified by Asian standards; 2) high triglyceride level (≥150mg/dL); 3) low level of high density lipoprotein (<40 mg/dL); 4) high blood pressure (≥130/85 mmHg); 5) high fasting plasma glucose (≥100mg/dL); 6) current medication for treatment of any of the above conditions such as statins, anti-hypertensive drugs, anti-diabetic medications, according to the 2009 consensus criteria and the waist circumference criteria of the Regional Office for the Western Pacific Region of World Health Organization (Alberti et al., 2009) .
Statistical Analysis
The calculated sampling weights were available from the KNHANES dataset to consider the sampling and response rates. This was particularly important for survey data because the sampling probabilities could be different among sampling clusters (Lehtonen and Pahkinen, 2004) . Thus, we used the sampling weights that the KNHANES provided for all of the data analyses in this study. All estimates in the analysis were properly weighted to represent the general population. Descriptive statistical methods were used to demonstrate the basic characteristics of the study population; estimated proportion and standard errors were reported for each variable. The prevalence of each component of metabolic syndrome was measured according to cancer survivors and non-cancer controls. We evaluated the adjusted proportion of metabolic syndrome according to each cancer type (gastric, colon, breast, cervix uteri) and non-cancer controls. Multi-dimensional approach to identify factors associated with metabolic syndrome SE, standard error; a Heavy drinking defined as self-reported more than 5 drinks on a single occasion, or daily drinking of more than 1 drink per day;
b Adequate physical activity defined as doing 30 minutes of moderate-intensity physical activity on 5 or more days of the week or 20 minutes of vigorous− intensity physical activity on 3 or more days of the week among cancer survivors was used. First, odds ratios (OR) for metabolic syndrome were calculated by univariate analysis. Then, multiple logistic regression analysis was performed by adjusting socio-demographic factors, psychological factors, behavioral factors, and oncological factors. Adjusted odds ratio (aOR) and 95% confidence intervals (CI) were calculated to show the strength of each association. P-values less than 0.05 were considered significant, and all statistical tests were twosided. All statistical tests were performed using STATA 11.0 (Stata Corp., College Station, Texas, USA).
Results
Baseline characteristics
A positive cancer history was reported by approximately 3% of the study population. The baseline characteristics of study participants are summarized in Table 1 . Cancer survivors were older than non-cancer controls (≥ 60 years: 51.2% vs. 31.4%, respectively), and more likely to be female (65.1% vs. 51.1%, respectively). Cancer survivors were less likely to be obese than the general population (BMI ≥25: 30.5% vs. 36.6%, respectively). High risk behaviors such as smoking and heavy alcohol drinking were less likely to be observed in cancer survivors than in non-cancer controls (current smoking: 9.7% vs. 22.7% and heavy alcohol consumption 8.1% vs. 28.9%, respectively). Among cancer survivors, gastric cancer was the most common cancer (23%), followed by cervix uteri (21.2%), breast cancer (16.3%), and colon cancer (9.8%). Approximately 50% survived more than 5 years after diagnosis.
Metabolic syndrome components among cancer survivors and non-cancer controls
The crude proportions of metabolic syndrome were 28.5% in cancer survivors and 33.5% in the general population, respectively. Table 2 showed the prevalence of each metabolic syndrome component according to cancer status. The prevalence of elevated blood pressure, systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥85 mmHg, was 30.9% in cancer survivors and 38.7% in non-cancer controls (P = 0.02). In addition, the crude proportion of elevated triglycerides was 23.1% in cancer survivors and 35.3% in the general populations (P < 0.001). The risk for metabolic syndrome among cancer survivors was lower than non-cancer controls, but this association was not statistically significant (aOR 0.80, 95% CI 0.56−1.14). Gastric cancer survivors showed decreased aOR for metabolic syndrome than non-cancer controls (aOR 0.42, 95% CI 0.20−0.86). When we evaluated cancer survivors by excluding gastric cancer survivors, a similar risk for metabolic syndrome was observed compared to non-cancer controls (aOR 0.96, 95% CI 0.64−1.45). Colon cancer and breast cancer survivors had higher risk for metabolic syndrome than non-cancer controls, but none of them were statistically significant.
We separated our sample into two subgroups according to age group (40−59 years and ≥60 years) and performed a subgroup analysis. We did not find a significant difference in the risk of metabolic syndrome between cancer survivors and non-cancer controls across different age groups. In participants who aged 40−59 years, cancer survivors were not at higher risk for metabolic syndrome compared to non-cancer controls (aOR 0.66, 95% CI 0.34−1.28). Similarly in the older age group (≥60 years), cancer survivors did not have significantly different risk for metabolic syndrome 
Factors associated with metabolic syndrome among cancer survivors
The factors shown to be associated with metabolic syndrome by univariate analysis (Model 1) were age group, BMI, and cancer type ( 
Discussion
In this study, cancer survivors had similar or even better metabolic syndrome component compared to the non-cancer controls. Among Korean cancer survivors aged ≥40years, 28.5% had metabolic syndrome. Previous studies from western countries have demonstrated that the results varied according to cancer types. Cancer survivors from hematologic malignancies showed higher odds ratios for metabolic syndrome (Kourti et al., 2005; Follin et al., 2006; Gurney et al., 2006; Trimis et al., 2007) . However, inconsistent results were observed in cancer survivors with solid tumors (Nuver et al., 2005; Braga-Basaria et al., 2006; Haugnes et al., 2007) . Based on the Third National Health and Nutrition Examination, U.S. population-based surveys, the prevalence of metabolic syndrome was higher among cancer survivors than non-cancer controls (Ness et al., 2005) . In Korea, the distribution of prevalent cancer type is different from Western countries. Furthermore, there are few studies about the associations between the gastric cancer and metabolic syndrome, which is one of the most common cancers in Korea.
Gastric cancer patients had lower risk for metabolic syndrome compared to the general population. Gastrectomy is the gold standard for curative treatment modality performed on gastric cancer patients (Brennan and Karpeh, 1996) . Previous studies have shown that poor nutritional status was observed in patients who had undergone gastrectomy (Bae et al., 1998; Carey et al., 2011) . After the operation, severe fat malnutrition and vitamin deficiency were found (Bae et al., 1998) . Major upper gastrointestinal surgery affects permanent alterations to the gastrointestinal tract, and therefore results in weight loss, body change, and malabsorption (Carey et al., 2011) . Moreover, bariatric surgery can provide sustained weight loss and reduced obesity-related mortality by reducing gastric size (Ashrafian et al., 2011) . Heavy drinking defined as self−reported more than 5 drinks on a single occasion, or daily drinking of more than 1 drink per day; b Adequate physical activity defined as doing 30 minutes of moderate−intensity physical activity on 5 or more days of the week or 20 minutes of vigorous−intensity physical activity on
Although there are few studies about the association between gastric cancer and metabolic syndrome, we could explain the lower prevalence of metabolic syndrome among Korean cancer survivors through the relatively high proportions of gastric cancer patients in Korea. Despite failing to show statistical significance, breast cancer and colon cancer survivors had higher aOR for metabolic syndrome than non-cancer controls. There can be an increasing prevalence for metabolic syndrome in the near future due to the increasing trend of breast and colon cancer and the decreasing trend of gastric cancer in Korea (Jung et al., 2011) .
General risk factors for metabolic syndrome are female, old age, high BMI, current smoking status, heavy alcohol consumption, inadequate physical activity and low socio-economic level (Park et al., 2004; Erem et al., 2008; Mohamud et al., 2011; Rodrigues et al., 2013) . In our study, only 2 risk factors (age and BMI) among many variables showed a significant association with metabolic syndrome in cancer survivors. Age is well accepted to be one of the strongest predictor of metabolic syndrome in the general population (Riediger and Clara, 2011) . This finding is consistent with those of other studies carried out in Korea as well as worldwide (Ford et al., 2002; Park et al., 2004; Erem et al., 2008; Mohamud et al., 2011; Rodrigues et al., 2013 ) . This association is due to the inevitable physiological processes of aging, such as declining basal metabolic rate, changes in body composition, and unhealthy lifestyle (Bechtold et al., 2006) . While muscle mass decreases up to 40% from 20 to 70 years of age (Villareal et al., 2005) , fat mass increases with the predominance of abdominal fat accumulation (Visser et al., 1998) , and these aging-related changes lead to increasing intra-abdominal fat, specifically central obesity, which is associated with cardiovascular disease risk factors (Grinker et al., 1995; Bo et al., 2009) . Management of metabolic syndrome in the elderly is difficult because co-management of multiple co-morbid conditions is often required (Bechtold et al., 2006) . Especially for cancer survivors, a higher proportion of non-cancer mortalities was observed in the elderly than the younger age-group (Shin et al., 2010a) . Moreover, cancer survivors were less likely to have an appropriate medication adherence, and the proportion of adherence was lower in the old age group than in the young age group (Shin et al., 2010b) . Considering the previously mentioned aspects, treatment of metabolic syndrome among elderly cancer survivors is one of the most challenging issues. Therefore, primary prevention and early intervention should be required to manage the metabolic syndrome among cancer survivors, especially for the elderly.
We observed that aOR increased with higher BMI when adjusting for other variables, and that BMI was the most sensitive marker for the metabolic syndrome. This finding is consistent with previous studies from general population in Korea and the United States (Park et al., 2003; Park et al., 2004) . The pathophysiology of the metabolic syndrome is largely attributable to insulin resistance. Overweight, obesity, and especially a central pattern of fat accumulation are related to insulin resistance (Lechleitner, 2008) . Obesity is associated with cancer recurrence and mortality in some cancer types such as breast, colon, and prostate cancer (Meyerhardt et al., 2003; Amling et al., 2004; Whiteman et al., 2005) . Obese survivors in cancers with high long-term survival, such as breast, colon, and prostate cancers, may have greater chance to be exposed to the obesityrelated co-morbidities and mortalities than patients with aggressive cancers (Park et al., 2006) . Moreover, treatment-related weight gain is often observed in breast and prostate cancer patients due to hormonal therapy or reduced physical activity (Tayek et al., 1990; Chlebowski et al., 2002) . Efforts to control weight may be a key strategy to reduce mortality from cancer as well as to prevent metabolic syndrome. In breast cancer survivors, significant reductions in fasting serum insulins and leptin as well as significant improvement in quality of life were observed with weight control intervention (Befort et al., 2012) .
As the number of long-term cancer survivors is growing, the evaluation and management of their health-related problems have become an important issue. Cardiovascular disease is the most common cause of non-cancer mortality in cancer survivors, and metabolic syndrome represents the link to the increased cardiovascular disease (Brown et al., 1993; Shin et al., 2010a) . Among cancer survivors, old age and high BMI are identified as risk factors for metabolic syndrome. It is important for the healthcare provider to assess and screen the metabolic syndrome of cancer survivors who are elderly and obese. While age and cancer type are nonmodifiable factors, BMI can be modifiable with efforts to control weight. Thus, weight control intervention program should be suggested for long-term cancer survivors to prevent metabolic syndrome.
Several limitations should be considered in our studies. First, we could not document causal association between factors and metabolic syndrome because of the cross-sectional nature of our study design (Forootan et al., 2012) . Because obesity is associated with increased risk for some cancer types such as breast and endometrial cancer, the causal relationship between obesity and cancer is obscure (Ronco et al., 2012) . In addition, Preexisting metabolic syndrome before diagnosis and treatment among cancer survivors could not be identified due to lack of available data. Second, several important information could not be collected from survey. We could not know treatment modalities of each patient from survey. Changes in endocrine and metabolic functions varied according to treatment modality such as systemic cancer therapy (hormone therapy and chemotherapy), and local treatments (radiation and surgery). Because several common cancer types such as liver, lung, thyroid and prostate cancer were included in other cancer groups, we could not estimate the precise association with metabolic syndrome in those cancer survivors. Therefore, information about various cancer types and treatment modalities should be included in future studies. Third, most of the information was from self-reported questionnaires, so reporting bias cannot be excluded. Moreover, we excluded incomplete data or non-participation in the survey.
In spite of these limitations, this study identified risk factors for metabolic syndrome among cancer survivors and suggested a strategy to prevent cardiovascular mortality. To the best of our knowledge, this is the first Asian study to evaluate the prevalence of metabolic syndrome between cancer survivors and non-cancer controls. Our study demonstrated that cancer survivors in Korea were not at an increased risk of metabolic syndrome. However, as cancer patterns are changing to a more Westernized style, there is an increasing trend in breast and colon cancer and a decreasing trend in gastric cancer. Therefore increasing metabolic syndrome in cancer survivors will be expected in the near future in Korea. Screening and treatment of the metabolic syndrome should be performed comprehensively considering disease status and risk factors of survivors, taking into account high risk groups identified here. Large scale cohort studies including information about various cancer types and treatment modalities are needed to investigate and evaluate the association between cancer survivors and metabolic syndrome.
